Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in AXGN — Axogen, Inc.

CIK 902219 Boston, MA
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$64,280,496
+$32,324,460 QoQ
Shares Held
1,391,654
+44.3% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 253 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 55% None 45%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $7,924,963,064 across 31 Medical Devices names. AXGN ranks #10 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SYK
Stryker Corp
 8,167,185 $2,571,356,522
2 EW
Edwards Lifesciences Corp
 16,827,967 $1,522,257,889
3 ABT
Abbott Laboratories
 8,304,709 $753,569,291
4 STE
STERIS plc
 3,502,897 $737,605,017
5 BSX
Boston Scientific Corp
 15,301,828 $653,082,016
6 DXCM
Dexcom Inc
 8,527,471 $574,325,169
7 MDT
Medtronic plc
 6,474,476 $506,498,254
8 LIVN
LivaNova PLC
 1,739,167 $143,011,699

All Filings in AXGN

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $64,280,496 1,391,654
2026-03-31 $31,956,036 964,565